An excerpt of EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Documents similaires

• An excerpt of diagnosis, evaluation, and management of ascites and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
  par: HU Jiaxuan
  Publié: (2021)
• An excerpt of Budd-Chiari syndrome: Consensus guidance of the Asian Pacific Association for the Study of the Liver (APASL)
  par: WANG Xueying
  Publié: (2021)
• Update on entecavir in the management of severe forms of Hepatitis B
  par: Sacco R
  Publié: (2012)
• Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
  par: Vander Naalt SJ, et autres
  Publié: (2014)
• Value of albumin-bilirubin grade in predicting liver function changes and prognosis of hepatocellular carcinoma patients undergoing transarterial chemoembolization: A Meta-analysis
  par: YU Weiming
  Publié: (2021)